A fundamental shift is taking place in the way companies are approaching regulatory compliance. A lack of structured data is proving to be a substantial liability—as ill-prepared companies are learning the hard way—which is leading more organizations to move away from conventional document-centric methodologies and toward a data-centered model of compliance.
This trend is particularly pronounced in the life sciences where companies have traditionally been mired in mountains of documentation because they tend to base their analyses and reporting activities on historical data. But as Big Data continues to get bigger and harder to manage, more companies are finding their compliance information trapped in documents that are siloed in disparate systems or inaccessible when needed most.